• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Recent Advances in the Study of AMINO(4-PROPOXYPHENYL)ACETIC ACID (CAS: 500695-51-2) in Chemical Biology and Pharmaceutical Research

AMINO(4-PROPOXYPHENYL)ACETIC ACID (CAS: 500695-51-2) has recently emerged as a compound of significant interest in chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has been the subject of several studies aimed at exploring its potential applications in drug development and therapeutic interventions. The growing body of research underscores its relevance in addressing unmet medical needs, particularly in the areas of inflammation, metabolic disorders, and neurodegenerative diseases.

Recent studies have focused on the synthesis and optimization of AMINO(4-PROPOXYPHENYL)ACETIC ACID to enhance its bioavailability and therapeutic efficacy. Advanced computational modeling and high-throughput screening techniques have been employed to elucidate its mechanism of action and identify potential biological targets. These efforts have revealed promising interactions with key enzymes and receptors involved in inflammatory pathways, suggesting its potential as a novel anti-inflammatory agent.

In vitro and in vivo studies have demonstrated the compound's ability to modulate specific biochemical pathways, with notable effects on cytokine production and oxidative stress markers. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that AMINO(4-PROPOXYPHENYL)ACETIC ACID exhibited significant inhibitory activity against COX-2, an enzyme implicated in inflammatory processes. These findings highlight its potential as a candidate for further development in the treatment of chronic inflammatory conditions.

Another area of active research involves the exploration of AMINO(4-PROPOXYPHENYL)ACETIC ACID's role in metabolic regulation. Preliminary data from animal models indicate that the compound may influence glucose metabolism and insulin sensitivity, positioning it as a potential therapeutic for type 2 diabetes and related metabolic disorders. Researchers are currently investigating its pharmacokinetic properties and safety profile to assess its suitability for clinical trials.

Despite these promising developments, challenges remain in optimizing the compound's stability and delivery mechanisms. Recent advancements in nanotechnology and drug formulation are being explored to address these issues, with the aim of enhancing the compound's therapeutic potential. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications.

In conclusion, AMINO(4-PROPOXYPHENYL)ACETIC ACID (CAS: 500695-51-2) represents a promising avenue for future research in chemical biology and drug development. Its multifaceted biological activities and potential therapeutic applications warrant further investigation, particularly in the context of inflammation and metabolic diseases. Continued interdisciplinary research will be essential to fully realize its clinical potential and address the remaining challenges in its development.

• 318270-09-6(Amino(4-isopropoxyphenyl)acetic Acid)
• 126746-19-8(Amino(4-Butoxyphenyl)Acetic Acid)
• 19789-59-4(2-Amino-2-(4-methoxyphenyl)acetic acid)
• 299168-49-3(Amino(4-ethoxyphenyl)acetic Acid)
• 24593-48-4((2S)-2-amino-2-(4-methoxyphenyl)acetic acid)
• 299168-94-8(AMINO(3-PHENOXYPHENYL)ACETIC ACID)
• 24593-49-5((2R)-2-amino-2-(4-methoxyphenyl)acetic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)